Beta Glucan's Effect on Pembrolizumab Immunologic Response in Stage III-IV Melanoma
Beta Glucan's Effect on Pembrolizumab Immunologic Response in Stage III-IV Melanoma
Recruiting · NCT04513028 · Registry updated 2025-10-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Beta Glucan's Effect on Pembrolizumab Immunologic Response in Stage III-IV Melanoma | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm | Recruiting | Not applicable | 2025-10-30 | NCT04513028 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Kelly McMasters | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Louisville | Louisville | United States | 83 |